Intrepid Potash (IPI)
(Real Time Quote from BATS)
$19.50 USD
-0.23 (-1.17%)
Updated Apr 25, 2024 02:48 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Price, Consensus and EPS Surprise
IPI 19.50 -0.23(-1.17%)
Will IPI be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for IPI based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for IPI
Nutrien (NTR) Gains on Strong Demand Amid Pricing Woes
Zacks Industry Outlook Highlights CF Industries, ICL Group and Intrepid Potash
IPI: What are Zacks experts saying now?
Zacks Private Portfolio Services
3 Fertilizer Stocks to Watch Amid Industry Headwinds
Intrepid Potash (IPI) Q4 Earnings Lag, Sales Beat Estimates
Intrepid (IPI) Enters Into Third Amendment to Agreement With XTO
Other News for IPI
Intrepid Announces Date for First Quarter 2024 Earnings Release
Intrepid Announces Medical Leave of Absence for Bob Jornayvaz; Intrepid Co-founder Hugh Harvey rejoins Board of Directors
Intrepid Potash grants temporary medical leave of absence to CEO Bob Jornayvaz
Intrepid Potash Announces Leadership Changes and Strategic Shift
Intrepid Potash grants CEO Bob Jornayvaz temporary medical leave of absence